About
Sam Fazeli is a London-based pharmaceuticals and biotech equity-research analyst currently serving as Director of Research, Global Industries at Bloomberg Intelligence. He has more than 25 years of sector experience, including prior roles at Nomura International, HSBC, and Piper Jaffray, and previously worked as a research scientist. He also serves as a non-executive director of Arecor, a biotech company focused on biopharmaceutical formulation and diabetes-related products.
Areas of interest
biotechpharmaceuticalshealthcare marketsequity researchdiabetesmetabolic diseasesbiopharma financings